The macrophage-drug conjugate (MDC) as a “Trojan horse” approach in cancer therapy

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Taciak, B., Białasek M., Kucharzewska-Siembieda P., Kiraga Ł., Szulc A., Górka, E., Kubiak M., Pilch Z., Tonecka K., Sas Z., Braniewska A., Cheda Ł., Rogulski Z., Godlewski M., Boffi A., Rygiel T., Król M

Journal title: Proceedings of the AACR Special Conference on Tumor Immunology and Immunotherapy; 2018 Nov 27-30; Miami Beach, FL. Philadelphia (PA)

Journal number: Volume 8, Issue 4 Supplement, pp. B24

Journal publisher: American Association for Cancer Research

Published year: 2020

DOI identifier: 10.1158/2326-6074.tumimm18-b24